Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: BLCO )

15.33 +0.08 (+0.52%)
Official Closing Price Updated: 7:00 PM EDT, Jul 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 270,100
Open 15.19
Bid (Size) 14.67 (1)
Ask (Size) 15.57 (1)
Prev. Close 15.25
Today's Range 15.10 - 15.47
52wk Range 13.16 - 21.23
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief
From Bausch + Lomb Corporation
Via Business Wire
Why Is Clearside Biomedical Stock Gaining Today?
Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS... 
Via Benzinga

Performance

YTD
-9.40%
-9.40%
1 Month
+2.13%
+2.13%
3 Month
-6.64%
-6.64%
6 Month
-3.46%
-3.46%
1 Year
-22.30%
-22.30%

More News

Read More
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
From Bausch + Lomb Corporation
Via Business Wire
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Via Benzinga
Topics Stocks
Exposures US Equities
Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®
From Bausch + Lomb Corporation
Via Business Wire
Barclays Maintains Equal-Weight Rating for Bausch & Lomb: Here's What You Need To Know
Via Benzinga
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens
From Bausch + Lomb Corporation
Via Business Wire
Do You Have Your Eye On Vision Care Stocks?
Via Talk Markets
American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
BLCO Stock Earnings: Bausch & Lomb Meets EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Bausch + Lomb Announces First-Quarter 2024 Results
From Bausch + Lomb Corporation
Via Business Wire
Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally
Via Benzinga
Topics Economy
Exposures Interest Rates
Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors
From Bausch + Lomb Corporation
Via Business Wire
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Eye Care-Focused Bausch + Lomb's Stock Surges On Upbeat Annual Guidance Despite Deeper Losses
Via Benzinga
Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
From Emergent BioSolutions
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.